APA (7th ed.) Citation

Vuchkovska, A., Glanville, D. G., Scurti, G. M., Nishimura, M., White, P., Ulijasz, A. T., & Iwashima, M. (2022). Siglec‐5 is an inhibitory immune checkpoint molecule for human T cells. Immunology, 166(2), 238. https://doi.org/10.1111/imm.13470

Chicago Style (17th ed.) Citation

Vuchkovska, Aleksandra, David G. Glanville, Gina M. Scurti, Michael I Nishimura, Paula White, Andrew T. Ulijasz, and Makio Iwashima. "Siglec‐5 Is an Inhibitory Immune Checkpoint Molecule for Human T Cells." Immunology 166, no. 2 (2022): 238. https://doi.org/10.1111/imm.13470.

MLA (9th ed.) Citation

Vuchkovska, Aleksandra, et al. "Siglec‐5 Is an Inhibitory Immune Checkpoint Molecule for Human T Cells." Immunology, vol. 166, no. 2, 2022, p. 238, https://doi.org/10.1111/imm.13470.